USP39 and nasopharyngeal carcinoma: LINC00520 affects the process of malignant progression of nasopharyngeal carcinoma by antagonizing the expression level of USP39 regulated by miR-26b-3p (47), suggesting that USP39 may play a role as a regulator in nasopharyngeal carcinoma.